Acasti Pharma Inc (ACST)

Acasti Pharma Inc 주식(ACST)의 최신 뉴스

Has Acasti Pharma (ACST) Outpaced Other Medical Stocks This Year? - Yahoo Movies UK

Yahoo Movies UK

Financial Comparison: ADC Therapeutics (NYSE:ADCT) vs. Acasti Pharma (NASDAQ:ACST) - Defense World

Defense World

We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate - Simply Wall St

Simply Wall St

Acasti: Fiscal Q3 Earnings Snapshot - Quartz

Quartz

Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial

GlobeNewswire Inc.

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday’s Mid-Day Sessi - Benzinga

Benzinga

Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024

GlobeNewswire Inc.

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc. - NutraIngredients-usa.com

NutraIngredients-usa.com

Best Pharmaceutical Penny Stocks to Buy Now - Investment U

Investment U

Acasti Announces WuXi Clinical as CRO to Conduct STRIVE-ON Pivotal Phase 3 Safety Trial for GTX-104 in aSAH ... - PR Newswire

PR Newswire

Acasti Pharma Announces 1-for-6 Reverse Stock Split - PR Newswire

PR Newswire

After laying off most staff, Acasti insists it's still on track - Fierce Biotech

Fierce Biotech

Acasti submits aSAH Phase III safety study protocol to FDA - Clinical Trials Arena

Clinical Trials Arena

Acasti Successfully Submits Pivotal GTX-104 Phase 3 Safety Study Protocol with FDA and Implements Strategic ... - PR Newswire

PR Newswire

Acasti to Proceed with Phase 3 Clinical Safety Study for GTX-104 Following FDA Feedback, and Upon Approval of the ... - PR Newswire

PR Newswire

Acasti Pharma Inc. Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture ... - PR Newswire

PR Newswire

Acasti Pharma Reports Third Quarter 2023 Operational Results - GlobeNewswire

GlobeNewswire

Acasti reports results from ataxia telangiectasia therapy trial - Clinical Trials Arena

Clinical Trials Arena

Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication ... - PR Newswire

PR Newswire

Acasti Pharma Inc. - Osler, Hoskin & Harcourt LLP

Osler, Hoskin & Harcourt LLP

US-based Acasti Pharma to buy Indian origin pharma firm Grace - The Economic Times

The Economic Times

Look Anywhere but Acasti Pharma Stock for Opportunity - InvestorPlace

InvestorPlace

Acasti Pharma could have a winner on its hands, says Encode Ideas - Cantech Letter

Cantech Letter

Acasti Pharma Inc. - Osler, Hoskin & Harcourt LLP

Osler, Hoskin & Harcourt LLP

Acasti Pharma Inc. - Osler, Hoskin & Harcourt LLP

Osler, Hoskin & Harcourt LLP

40 Stocks Moving In Tuesday's Mid-Day Session - Acasti Pharma (NASDAQ:ACST) - Benzinga

Benzinga

ACST Stock Price and Chart — NASDAQ:ACST - TradingView

TradingView

Neptune Technologies & Bioressources Inc. Enters Pharmaceutical Market With Onemia(TM) Launch by Acasti Pharma Inc. - NBC News

NBC News